HoltMKRichardsJECookDRBrierleyDIWilliamsDLReimannFet al
Can I get peptides from a compounding pharmacy without a prescription
Off-Label Use: What Clinicians Should Consider Despite the absence of an approved indication, some pediatric obesity specialists have reported considering off-label GLP-1 receptor agonist use in select children aged 10 to 11 with severe obesity (BMI at or above the 120th percent of the 95th percentile) and weight-related comorbidities such as type 2 diabetes, obstructive sleep apnea, or nonalcoholic steatohepatitis
W., Luo, D., Chen, D., Zhou, H., Zhang, X
No MHRA or CE approval, no FDA approval, no published clinical trial data of the type that would support typical UK prescribing